TNFRSF1A and peripheral arterial disease: In another study, plasma concentrations of biomarkers such as TNF receptor 1 (TNFR1), fluorescent advanced glycation end products (F-AGEs), IMA, and total reductive capacity of plasma (TRCP) were evaluated for their predictive value in PAD among individuals with type 2 diabetes [18].